Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3 Business Technology Group Regulatory News (KBT)

  • There is currently no data for KBT

Contract Wins

25 Feb 2005 07:00

K3 Business Technology Group PLC25 February 2005 K3 BUSINESS TECHOLOGY GROUP PLC ("K3") ANNOUNCES NEW CONTRACTS WINS K3, the IT solutions provider to the manufacturing, distribution and retailsectors, is pleased to announce that its subsidiaries, K3 Landsteinar and K3Elucid ("Elucid"), have won new contracts with a total value of approximately£1.05m. K3 Landsteinar, acquired in October 2004, has secured three new contracts tosupply its retail management software, worth a total of £750,000. The largest isa £300,000 deal with a leading independent homeware and fashion retailer. Thesecond, worth £250,000, provides a complete business solution for a retailer ofbeauty products. The third is a contract for approximately £200,000 with ahigh-street electronics retailer. Elucid, which supplies warehousing and distribution software and was acquired inApril 2004, has signed a contract worth £300,000 with Scotts of Stow, themail-order specialist. Elucid is to install a complete distribution solution,encompassing all the retailer's sales channels, on-line, catalogue and stores. Andy Makeham, CEO, of K3 commented, "I am delighted to announce these new contract wins. They demonstrate thestrength of K3 Landsteinar's and Elucid's product offering and confirms our viewthat both acquisitions have excellent growth prospects." Enquiries: K3 Business Technology Group T: 01282 864111Andy Makeham, Chief ExecutiveDavid Bolton, Finance Director Biddicks T: 020 7448 1000Katie Tzouliadis This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Nov 20215:36 pmRNSDirector/PDMR Shareholding
22nd Nov 20214:43 pmRNSPDMR Announcement
15th Nov 20212:30 pmRNSDirector/PDMR Shareholding
10th Nov 20215:06 pmRNSPDMR Announcement
18th Oct 202112:48 pmRNSPDMR Announcement
4th Oct 20213:00 pmRNSPDMR Announcement
27th Sep 20212:03 pmRNSPDMR Announcement
22nd Sep 202111:02 amRNSPDMR Announcement
20th Sep 20217:00 amRNSSale of Sage Business for £1.68m cash
26th Jul 20217:00 amRNSInterim Results
1st Jul 202111:37 amRNSHolding(s) in Company
21st Jun 20214:00 pmRNSPDMR Announcement
18th Jun 20214:54 pmRNSMarket Price Share Option Scheme
14th Jun 20218:08 amRNSPDMR Announcement
2nd Jun 202111:45 amRNSHolding(s) in Company
1st Jun 202110:46 amRNSPDMR Announcement
19th May 20211:30 pmRNSResult of AGM
12th May 20215:57 pmRNSDirector/PDMR Share Purchase
5th May 20211:43 pmRNSPDMR Announcement
4th May 20212:52 pmRNSDirector/PDMR Share Purchase
23rd Apr 20217:00 amRNSNotice of AGM and Posting of Annual Report
9th Apr 20212:49 pmRNSHolding(s) in Company
9th Apr 20212:47 pmRNSHolding(s) in Company
9th Apr 20212:46 pmRNSHolding(s) in Company
6th Apr 20214:59 pmRNSPDMR Announcement
30th Mar 20217:30 amRNSShareholder Loan Conversion
30th Mar 20217:30 amRNSLong Term Incentive Plan Option Scheme
30th Mar 20217:00 amRNSFinal Results
30th Mar 20217:00 amRNSAppointment of Chief Executive Officer
5th Mar 20217:00 amRNSBoard Change
1st Mar 20213:54 pmRNSHolding(s) in Company
26th Feb 20217:00 amRNSSale of subsidiary
13th Nov 20207:00 amRNSLong Term Incentive Plan
12th Nov 20207:00 amRNSPDMR Announcement
2nd Nov 20207:00 amRNSTrading Update
28th Oct 20207:00 amRNSAppointment of Chairman
28th Aug 202011:05 amRNSResult of General Meeting
12th Aug 20207:57 amRNSPDMR Announcement
11th Aug 20204:41 pmRNSSecond Price Monitoring Extn
11th Aug 20204:36 pmRNSPrice Monitoring Extension
10th Aug 20204:03 pmRNSPDMR Announcement
4th Aug 20207:00 amRNSInterim Results
29th Jul 20205:25 pmRNSNotice of General Meeting & Posting Annual Report
27th Jul 20207:00 amRNSFinal Results
15th Jul 20203:15 pmRNSNotice of Results
22nd Jun 20207:00 amRNSNotice of Results
29th May 202012:11 pmRNSResult of AGM
29th May 20207:00 amRNSAGM and Notice of Results
5th May 20209:47 amRNSNotice of AGM
3rd Apr 20205:08 pmRNSPDMR Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.